Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in gliomaFan Zeng, Zheng Zhao|Cell Communication and Signaling|2020Cited by 51
WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous SystemZheng Zhao, Tao Jiang, Ruichao Chai et al.|Scientific Data|2022Cited by 17
Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort PatientsZenghui Qian, Zheng Zhao, Wenhua Fan et al.|Frontiers in Cell and Developmental Biology|2021Cited by 15
MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitorsKenan Zhang, Tao Jiang, Zheng Zhao et al.|Holistic Integrative Oncology|2022Cited by 5